4//SEC Filing
ABBOTT MEDICAL OPTICS INC 4
Accession 0001256928-09-000010
CIK 0001168335operating
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 7:53 PM ET
Size
78.3 KB
Accession
0001256928-09-000010
Insider Transaction Report
Form 4
POST DOUGLAS H
Other
Transactions
- Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−286$6,292→ 0 total - Award
Common Stock
2009-02-25+2,540→ 2,540 total - Tax Payment
Common Stock
2009-02-25$22.01/sh−1,163$25,598→ 1,377 total - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−35,417→ 0 totalExercise: $23.58From: 2005-05-27Exp: 2012-02-12→ Common Stock (35,417 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−45,000→ 0 totalExercise: $38.50From: 2009-02-25Exp: 2019-05-27→ Common Stock (45,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−55,900→ 0 totalExercise: $42.55From: 2009-02-25Exp: 2017-05-21→ Common Stock (55,900 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−85,000→ 0 totalExercise: $22.94From: 2009-02-25Exp: 2018-05-29→ Common Stock (85,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−38,000→ 0 totalExercise: $45.26From: 2009-02-25Exp: 2016-05-24→ Common Stock (38,000 underlying) - Disposition from Tender
Common Stock
2009-02-25$22.00/sh−7,050$155,100→ 9,377 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−9,377$206,294→ 0 total - Award
Common Stock
2009-02-25+528→ 528 total - Tax Payment
Common Stock
2009-02-25$22.01/sh−242$5,326→ 286 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−1,377$30,294→ 0 total - Award
Common Stock
2009-02-25+3,404→ 3,404 total - Tax Payment
Common Stock
2009-02-25$22.01/sh−1,558$34,292→ 1,846 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−1,846$40,612→ 0 total - Award
Common Stock
2009-02-25+473→ 473 total - Tax Payment
Common Stock
2009-02-25$22.01/sh−217$4,776→ 256 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−256$5,632→ 0 total - Award
Common Stock
2009-02-25+1,055→ 1,055 total - Tax Payment
Common Stock
2009-02-25$22.01/sh−483$10,631→ 572 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−572$12,584→ 0 total - Award
Common Stock
2009-02-25+2,963→ 2,963 total - Tax Payment
Common Stock
2009-02-25$22.01/sh−1,356$29,846→ 1,607 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−1,607$35,354→ 0 total - Award
Common Stock
2009-02-25+2,417→ 2,417 total - Tax Payment
Common Stock
2009-02-25$22.01/sh−1,106$24,343→ 1,311 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−1,311$28,842→ 0 total - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−4.328$95→ 0 total(indirect: By Trust) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−5,250→ 0 totalExercise: $40.20From: 2005-05-27Exp: 2010-02-17→ Common Stock (5,250 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−535→ 0 totalExercise: $24.54From: 2005-05-27Exp: 2011-02-12→ Common Stock (535 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−4,723→ 0 totalExercise: $23.58From: 2005-05-27Exp: 2012-02-12→ Common Stock (4,723 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−2,174→ 0 totalExercise: $34.46From: 2005-05-27Exp: 2013-07-23→ Common Stock (2,174 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−2,007→ 0 totalExercise: $30.73From: 2005-05-27Exp: 2014-02-11→ Common Stock (2,007 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−14,017→ 0 totalExercise: $40.20From: 2005-05-27Exp: 2010-02-17→ Common Stock (14,017 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−12,309→ 0 totalExercise: $24.51From: 2005-05-27Exp: 2011-02-12→ Common Stock (12,309 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−94,163→ 0 totalExercise: $34.45From: 2005-05-27Exp: 2013-07-23→ Common Stock (94,163 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-26−46,161→ 0 totalExercise: $30.73From: 2005-05-27Exp: 2014-02-11→ Common Stock (46,161 underlying)
Footnotes (19)
- [F1]These shares were tendered to Rainforest Acquisition Inc. ("Purchaser") pursuant to Purchaser?s offer to purchase all of the outstanding shares of Advanced Medical Optics, Inc. (the "Issuer") at a cash purchase price of $22.00 per share, without interest, and subject to any required withholding taxes, subject to the terms described in the Offer to Purchase, filed with the SEC on January 27, 2009, as amended (the "Tender Offer"). Such shares were purchased by Purchaser pursuant to the Tender Offer on February 25, 2009.
- [F10]This previously reported exempt stock option, which was 100% vested at the time it was assumed by the issuer on May 27, 2005, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 823 shares of Abbott Laboratories common stock at an exercise price of $74.90 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F11]This previously reported exempt stock option, which was 100% vested at the time it was assumed by the issuer on May 27, 2005, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 5,751 shares of Abbott Laboratories common stock at an exercise price of $97.98 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F12]This previously reported exempt stock option, which was 100% vested at the time it was assumed by the issuer on May 27, 2005, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 5,050 shares of Abbott Laboratories common stock at an exercise price of $59.74 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F13]This previously reported exempt stock option, which was 100% vested at the time it was assumed by the issuer on May 27, 2005, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 14,531 shares of Abbott Laboratories common stock at an exercise price of $57.48 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F14]This previously reported exempt stock option, which was 100% vested at the time it was assumed by the issuer on May 27, 2005, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 38,634 shares of Abbott Laboratories common stock at an exercise price of $83.97 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F15]This previously reported exempt stock option, which was 100% vested at the time it was assumed by the issuer on May 27, 2005, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 18,939 shares of Abbott Laboratories common stock at an exercise price of $74.90 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F16]This previously reported exempt stock option, which became 100% vested on December 31, 2008 in connection with the reporting person's termination of employment, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 18,463 shares of Abbott Laboratories common stock at an exercise price of $93.84 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F17]This previously reported exempt stock option, which became 100% vested on December 31, 2008 in connection with the reporting person's termination of employment, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 15,591 shares of Abbott Laboratories common stock at an exercise price of $110.32 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F18]This previously reported exempt stock option, which became 100% vested on December 31, 2008 in connection with the reporting person's termination of employment, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 22,935 shares of Abbott Laboratories common stock at an exercise price of $103.71 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F19]This previously reported exempt stock option, which became 100% vested on December 31, 2008 in connection with the reporting person's termination of employment, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 34,875 shares of Abbott Laboratories common stock at an exercise price of $55.92 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F2]These shares were canceled pursuant to the Agreement and Plan of Merger, dated January 11, 2009, by and among Abbott Laboratories, Purchaser and the Issuer (the "Merger Agreement"), in exchange for the right to receive cash payment of $22.00 per share in cash (without interest and subject to any required withholding taxes) at the effective time of the merger.
- [F3]Exempt restricted shares of common stock forfeited in connection with termination of employment were reinstated pursuant to change in control agreement.
- [F4]Shares withheld in satisfaction of tax obligations attributable to the lapse of restrictions on stock award or in satisfaction of tax withholding attributable to vesting and settlement of restricted stock units.
- [F5]The exempt restricted stock units (previously reported on Table II) that had been forfeited in connection with the reporting person's termination of employment were reinstated pursuant to a change in control agreement, vested in full and were settled for shares of Issuer Common Stock in accordance with the terms of the applicable equity plan. At the effective time of the merger, such shares were cancelled pursuant to the Merger Agreement in exchange for the right to receive cash payment of $22.00 per share in cash (without interest and subject to any required withholding taxes).
- [F6]This previously reported exempt stock option, which was 100% vested at the time it was assumed by the issuer on May 27, 2005, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 2,154 shares of Abbott Laboratories common stock at an exercise price of $97.98 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F7]This previously reported exempt stock option, which was 100% vested at the time it was assumed by the issuer on May 27, 2005, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 219 shares of Abbott Laboratories common stock at an exercise price of $59.82 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F8]This previously reported exempt stock option, which was 100% vested at the time it was assumed by the issuer on May 27, 2005, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 1,937 shares of Abbott Laboratories common stock at an exercise price of $57.48 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F9]This previously reported exempt stock option, which was 100% vested at the time it was assumed by the issuer on May 27, 2005, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 891 shares of Abbott Laboratories common stock at an exercise price of $83.99 per share, determined pursuant to a formula set forth in the Merger Agreement.
Documents
Issuer
ABBOTT MEDICAL OPTICS INC
CIK 0001168335
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001168335
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 7:53 PM ET
- Size
- 78.3 KB